Difference between revisions of "Fabry Disease Selected Mutations"
(Created page with "We randomly selected ten annotated point mutations of the human gene GLA and they were chosen out of a pool of mutations that consist of two subsets. The first subset contains mu…") |
|||
Line 13: | Line 13: | ||
! Tool based |
! Tool based |
||
|- |
|- |
||
− | | 1 || 42 || ATG-ACG || Met -> Thr || [[Image:Fabry_Disease_1R47_res42_wt.png|thumb| |
+ | | 1 || 42 || ATG-ACG || Met -> Thr || [[Image:Fabry_Disease_1R47_res42_wt.png|thumb|150px|Close-up of the wildtype residue number 42 of GLA.]] || [[Image:Fabry_Disease_1R47_res42_mut.png|thumb|150px|Close-up of the mutated residue number 42 of GLA.]] ||[[Image:Fabry_Disease_1R47_res42_tool.png|thumb|150px|Close-up of the mutated residue number 42 of GLA.]] |
|- |
|- |
||
− | | 2 || 65 || AGT-ACG || Ser -> Thr || [[Image:Fabry_Disease_1R47_res65_wt.png|thumb| |
+ | | 2 || 65 || AGT-ACG || Ser -> Thr || [[Image:Fabry_Disease_1R47_res65_wt.png|thumb|150px|Close-up of the wildtype residue number 65 of GLA.]] || [[Image:Fabry_Disease_1R47_res65_mut.png|thumb|150px|Close-up of the mutated residue number 65 of GLA.]] || [[Image:Fabry_Disease_1R47_res65_tool.png|thumb|150px|Close-up of the mutated residue number 65 of GLA.]] |
|- |
|- |
||
− | | 3 || 117 || ATT-AGT || Ile -> Ser || [[Image:Fabry_Disease_1R47_res117_wt.png|thumb| |
+ | | 3 || 117 || ATT-AGT || Ile -> Ser || [[Image:Fabry_Disease_1R47_res117_wt.png|thumb|150px|Close-up of the wildtype residue number 117 of GLA.]] || [[Image:Fabry_Disease_1R47_res117_mut.png|thumb|150px|Close-up of the mutated residue number 117 of GLA.]] || [[Image:Fabry_Disease_1R47_res117_tool.png|thumb|150px|Close-up of the mutated residue number 117 of GLA.]] |
|- |
|- |
||
− | | 4 || 143 ||cGCA-ACA || Ala -> Thr || [[Image:Fabry_Disease_1R47_res143_wt.png|thumb| |
+ | | 4 || 143 ||cGCA-ACA || Ala -> Thr || [[Image:Fabry_Disease_1R47_res143_wt.png|thumb|150px|Close-up of the wildtype residue number 143 of GLA.]] || [[Image:Fabry_Disease_1R47_res143_mut.png|thumb|150px|Close-up of the mutated residue number 143 of GLA.]] || [[Image:Fabry_Disease_1R47_res143_tool.png|thumb|150px|Close-up of the mutated residue number 143 of GLA.]] |
|- |
|- |
||
− | | 5 || 186 || CAC-CGC || His -> Arg || [[Image:Fabry_Disease_1R47_res186_wt.png|thumb| |
+ | | 5 || 186 || CAC-CGC || His -> Arg || [[Image:Fabry_Disease_1R47_res186_wt.png|thumb|150px|Close-up of the wildtype residue number 186 of GLA.]] || [[Image:Fabry_Disease_1R47_res186_mut.png|thumb|150px|Close-up of the mutated residue number 186 of GLA.]] || [[Image:Fabry_Disease_1R47_res186_tool.png|thumb|150px|Close-up of the mutated residue number 186 of GLA.]] |
|- |
|- |
||
− | | 6 || 205 || gCCT-ACT || Pro -> Thr || [[Image:Fabry_Disease_1R47_res205_wt.png|thumb| |
+ | | 6 || 205 || gCCT-ACT || Pro -> Thr || [[Image:Fabry_Disease_1R47_res205_wt.png|thumb|150px|Close-up of the wildtype residue number 205 of GLA.]] || [[Image:Fabry_Disease_1R47_res205_mut.png|thumb|150px|Close-up of the mutated residue number 205 of GLA.]] || [[Image:Fabry_Disease_1R47_res205_tool.png|thumb|150px|Close-up of the mutated residue number 205 of GLA.]] |
|- |
|- |
||
− | | 7 || 244 || gGAC-CAC || Asp -> His || [[Image:Fabry_Disease_1R47_res244_wt.png|thumb| |
+ | | 7 || 244 || gGAC-CAC || Asp -> His || [[Image:Fabry_Disease_1R47_res244_wt.png|thumb|150px|Close-up of the wildtype residue number 244 of GLA.]] || [[Image:Fabry_Disease_1R47_res244_mut.png|thumb|150px|Close-up of the mutated residue number 244 of GLA.]] || [[Image:Fabry_Disease_1R47_res244_tool.png|thumb|150px|Close-up of the mutated residue number 244 of GLA.]] |
|- |
|- |
||
− | | 8 || 283 || CAG-CCG || Gln -> Pro || [[Image:Fabry_Disease_1R47_res283_wt.png|thumb| |
+ | | 8 || 283 || CAG-CCG || Gln -> Pro || [[Image:Fabry_Disease_1R47_res283_wt.png|thumb|150px|Close-up of the wildtype residue number 283 of GLA.]] || [[Image:Fabry_Disease_1R47_res283_mut.png|thumb|150px|Close-up of the mutated residue number 283 of GLA.]] || [[Image:Fabry_Disease_1R47_res283_tool.png|thumb|150px|Close-up of the mutated residue number 283 of GLA.]] |
|- |
|- |
||
− | | 9 || 321 || tCAG-TAG || Gln -> Glu || [[Image:Fabry_Disease_1R47_res321_wt.png|thumb| |
+ | | 9 || 321 || tCAG-TAG || Gln -> Glu || [[Image:Fabry_Disease_1R47_res321_wt.png|thumb|150px|Close-up of the wildtype residue number 321 of GLA.]] || [[Image:Fabry_Disease_1R47_res321_mut.png|thumb|150px|Close-up of the mutated residue number 321 of GLA.]] || [[Image:Fabry_Disease_1R47_res321_tool.png|thumb|150px|Close-up of the mutated residue number 321 of GLA.]] |
|- |
|- |
||
− | | 10 || 363 || TATa-TAA || Arg -> Cys || [[Image:Fabry_Disease_1R47_res363_wt.png|thumb| |
+ | | 10 || 363 || TATa-TAA || Arg -> Cys || [[Image:Fabry_Disease_1R47_res363_wt.png|thumb|150px|Close-up of the wildtype residue number 363 of GLA.]] || [[Image:Fabry_Disease_1R47_res363_mut.png|thumb|150px|Close-up of the mutated residue number 363 of GLA.]] || [[Image:Fabry_Disease_1R47_res363_tool.png|thumb|150px|Close-up of the mutated residue number 363 of GLA.]] |
|- |
|- |
||
|} |
|} |
Revision as of 05:10, 27 August 2011
We randomly selected ten annotated point mutations of the human gene GLA and they were chosen out of a pool of mutations that consist of two subsets. The first subset contains mutations that are present in HGMD and these mutations were already gathered in the task 4 Mapping SNPs. The second subset are mutations that are present in dbSNP, but not included in HGMD. This was only the case for three mutations.
Mutations at the amino acid position between 1 and 31 were not included in the selection process, because they are part of the signal peptide (see UniProt entry) and they are not present in the reference structure (PDB ID 1R47).
Number | AA-Position | Codon change | Amino acid change | Wildtype | Manual | Tool based |
---|---|---|---|---|---|---|
1 | 42 | ATG-ACG | Met -> Thr | |||
2 | 65 | AGT-ACG | Ser -> Thr | |||
3 | 117 | ATT-AGT | Ile -> Ser | |||
4 | 143 | cGCA-ACA | Ala -> Thr | |||
5 | 186 | CAC-CGC | His -> Arg | |||
6 | 205 | gCCT-ACT | Pro -> Thr | |||
7 | 244 | gGAC-CAC | Asp -> His | |||
8 | 283 | CAG-CCG | Gln -> Pro | |||
9 | 321 | tCAG-TAG | Gln -> Glu | |||
10 | 363 | TATa-TAA | Arg -> Cys |
The visualization was done by using PyMol and the mutagensis of the residue was performed according to this tutorial. The residue of the wildtype is colored green and the mutated residue is colored red.